Peripheral Arterial Disease (PAD) of the Femoropopliteal System is a major cause of morbidity and limb loss accounting for over 300,000 amputations in the developed world every year.
Medical therapy is often ineffective and open surgery has substantial risks. Less invasive endovascular approaches has been utilized for several decades in the Femoropopliteal System however, a major limiting factor was late restenosis.
Recent breakthroughs in stent material and design and the introduction of dedicated flexible stents with high radial force that can deliver superior outcome to open surgery promise to rewrite protocols of care and revolutionize the market for Lower Limb Endovascular Revascularization and Repair.
'Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast' report gives an overview of the state of both the technology and the market. It profiles the current market landscape and explores the market potential with global forecasts to 2010.
The report draws on the latest findings presented at EuroPCR conference and details many pressing issues in the Fem-Pop Angioplasty & Stenting space including current approved and in-development devices and the status of clinical development of potential new entrants.
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast is your exclusive introduction to top companies and their forward-thinking technologies.
Report Highlights:
- Current state of the science of superficial femoral artery (SFA) angioplasty & stenting.
- Recent clinical trials and their findings. - Epidemiology of PAD, CLI and estimated number of endovascular procedures.
- Current market for fem-pop angioplasty & stenting segmented geographically.
- Potential market for fem-pop angioplasty, stenting, brachytherapy, laser therapy and plaque excision.
- Leading players in the fem-pop angioplasty & stenting space and potential entrants. - Market forecasts to 2010.
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast gives a short but thorough analysis of the global potential market for superficial femoral artery (SFA) endovascular repair. It is targeted at busy executives & venture capitalists scanning for windows of opportunities opening in the peripheral endovascular space.
